|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.300 +0.050 (+20.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 50,476 | 36,210 | (135,335) | 26,204 |
| Net Cash from / (used in) Investing Activities | -- | (22,140) | 4,530 | 257,814 | 595,602 |
| Net Cash from / (used in) Financing Activities | -- | (28,972) | (46,676) | (124,798) | (624,245) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (636) | (5,936) | (2,319) | (2,439) |
| Cash & Cash Equivalents at beginning of period | -- | 1,916 | 4,364 | 3,317 | 28,198 |
| Effect of Foreign Exchange Rate Changes | -- | 240 | 3,488 | 3,366 | (17,923) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,520 | 1,916 | 4,364 | 7,836 |
| Remarks: | Real time quote last updated: 25/11/2024 14:01 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 661,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.000 |
| NBV Per Share (¥) | RMB -0.131 |